Sort
21,281 grants matching “influenza”
INFLAMMATORY MECHANISMS IN VIRAL OTITIS MEDIA
$193,619University Of North Carolina Chapel Hill · K23 · FY2004 · DC
Innate Control of Adaptive Immunity to SARS-CoV-2
$193,604Benjamin Goldman-Israelow · Yale University · K08 · FY2022 · AI
Development of a Novel rAAV Vector Without Cross-species Barrier to Transduce Human and Ferret Conducting Airways
$193,438Jianming Qiu · University Of Kansas Medical Center · R21 · FY2022 · AI
MATERNAL IMMUNIZATION TO PREVENT EARLY INFANT OTITIS MEDIA
$193,346University Of Minnesota Twin Cities · P50 · FY2001 · DC
MATERNAL IMMUNIZATION TO PREVENT EARLY INFANT OTITIS MEDIA
$193,346University Of Minnesota Twin Cities · P50 · FY2002 · DC
MATERNAL IMMUNIZATION TO PREVENT EARLY INFANT OTITIS MEDIA
$193,346University Of Minnesota Twin Cities · P50 · FY2000 · DC
Core D: Clinical Recruitment
$193,325Albert C Shaw · Yale University · U19 · FY2018 · AI
Pan-Influenza virus inhibitors: Small molecules that disrupt host ADAR1-viral NS1 interactions
$193,309Balaji Manicassamy · University Of Chicago · R21 · FY2016 · AI
Training in the Design and Development of Infectious Disease Therapeutics
$193,292Stephen W White · St. Jude Children'S Research Hospital · T32 · FY2018 · AI
Timely Risk Assessment of Airborne Virus with a Super-Efficient System for Viable Influenza Aerosol Capture
$193,277Chang-Yu Wu · University Of Florida · R21 · FY2017 · AI
EPIGENETIC PROGRAMMING OF INNATE IMMUNITY IN PEDIATRIC AIRWAY EPITHELIUM
$193,275Lisa A Miller · University Of California At Davis · R21 · FY2016 · AI
IMMUNOGENETICS AND FUNCTIONAL RESPONSE TO TYPE A INFLUENZA STRAINS
$193,235Jonathan Runstadler · University Of Alaska Fairbanks · P20 · FY2008 · RR
Bioinformatics Core: Core C
$193,233Rafick-Pierre Sekaly · Drexel University · U19 · FY2021 · AI
Hierarchical Modeling/Ion Channel and Receptor Mechanism
$193,221Maria G Kurnikova · Carnegie-Mellon University · R01 · FY2008 · GM
Hierarchical Modeling/Ion Channel and Receptor Mechanism
$193,221Maria G Kurnikova · Carnegie-Mellon University · R01 · FY2009 · GM
IGF::OT::IGF ADVANCE UNIVERSAL INFLUENZA VACCINE CANDIDATES BASED ON RBD-FERRITIN NANOPARTICLES
$193,201Matt Westerman · Leidos Biomedical Research, Inc. · N01 · FY2018 · CA
Role of ISG15 in Inhibition of Ebola Virus Budding
$193,134Ronald N. Harty · University Of Pennsylvania · R21 · FY2008 · AI
Immunity of aged mice after lifelong repeated live or killed influenza vaccines
$193,125Donna M Murasko · Drexel University · R21 · FY2012 · AG
Evaluation of CC mice as an improved model for influenza immunity
$193,125John T. Harty · University Of Iowa · R21 · FY2021 · AI
Broad Spectrum Anti-viral Compounds Targeting the SKI Complex
$193,125Matthew Bryan Frieman · University Of Maryland Baltimore · R21 · FY2021 · AI
Evaluating macrophage antiviral immunity as a suppressive factor in SIV-M. tuberculosis co-infection
$193,115Joshua T. Mattila · University Of Pittsburgh At Pittsburgh · R21 · FY2023 · AI
TLR Signaling in CD8 T Cell Response to Vaccinia Virus
$193,050Yiping Yang · Duke University · R21 · FY2010 · AI
Influenza virus small RNAs
$193,050Bryan R. Cullen · Duke University · R21 · FY2011 · AI
The interaction between outer membrane porins and toll-like receptors
$193,050T M Iverson · Vanderbilt University · R21 · FY2011 · AI
Pandemic preparedness for underserved persons in the US: Harnessing data from the RADx-UP consortium to assess public health tools for resource allocation
$193,000Shuchi Anand · Stanford University · R21 · FY2024 · MD